The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS
Open accessAbstract
Proceedings of the National Academy of Sciences (PNAS), a peer reviewed journal of the National Academy of Sciences (NAS) - an authoritative source of high-impact, original research that broadly spans the biological, physical, and social sciences.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ERSPAMER, V., & ASERO, B. (1952) · Nature · doi:10.1038/169800b0 · Cited by 670
Serotonin Content of Some Mammalian Tissues and Urine and a Method for Its Determination
Twarog, B. M., & Page, I. H. (1953) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1953.175.1.157 · Cited by 532
YOHIMBINE AND ERGOT ALKALOIDS AS NATURALLY OCCURRING ANTIMETABOLITES OF SEROTONIN
Shaw, E. N., & Woolley, D. W. (1953) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52368-7 · Cited by 74
Self-citationWoolley, D. W., & Shaw, E. N. (1953) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52615-1 · Cited by 40
Self-citation
Cited by
Molecular pathology of schizophrenia: more than one disease process?
Crow, T. J. (1980) · BMJ · doi:10.1136/bmj.280.6207.66 · Cited by 1,856
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Risperidone in the treatment of schizophrenia
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.6.825 · Cited by 1,193
Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895
Quinone chemistry and toxicity
Monks, T. J., Hanzlik, R. P., Cohen, G. M., Ross, D., & Graham, D. G. (1992) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(92)90273-u · Cited by 764
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
Weinberger, D. R. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800310013001 · Cited by 603
Serotonin model of schizophrenia: emerging role of glutamate mechanisms
Aghajanian, G. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00046-6 · Cited by 529
Crystal Structure of an LSD-Bound Human Serotonin Receptor
Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A. J., Levit, A., Lansu, K., Schools, Z. L., Che, T., Nichols, D. E., et al. (2017) · Cell · doi:10.1016/j.cell.2016.12.033 · Cited by 457
Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia
Phillips, W. A., & Silverstein, S. M. (2003) · Behavioral and Brain Sciences · doi:10.1017/s0140525x03000025 · Cited by 445
Vollenweider, F. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00246-1 · Cited by 444
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
Halberstadt, A. L., & Geyer, M. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.017 · Cited by 411
Lysergic acid diethylamide: Sensitive neuronal units in the midbrain raphe
Aghajanian, G. K., Foote, W. E., & Sheard, M. H. (1968) · Science · doi:10.1126/science.161.3842.706 · Cited by 404
Structure and function of serotonin G protein-coupled receptors
McCorvy, J. D., & Roth, B. L. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.009 · Cited by 372
Aghajanian, G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00135-3 · Cited by 371
The Role of Serotonin in Schizophrenia
Bleich, A., Brown, S.-L., Kahn, R., & van Praag, H. M. (1988) · Schizophrenia Bulletin · doi:10.1093/schbul/14.2.297 · Cited by 371
Waldinger, M. D., Berendsen, H. H. G., Blok, B. F. M., Olivier, B., & Holstege, G. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00183-6 · Cited by 369
The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches?
Roth, B. L., Lopez, E., Patel, S., & Kroeze, W. K. (2000) · The Neuroscientist · doi:10.1177/107385840000600408 · Cited by 358
History of the Discovery and Clinical Introduction of Chlorpromazine
López-Muñoz, F., Alamo, C., cuenca, E., Shen, W., Clervoy, P., & Rubio, G. (2005) · Annals of Clinical Psychiatry · doi:10.1080/10401230591002002 · Cited by 354
THE DISTRIBUTION OF SEROTONIN, 5‐HYDROXYTRYPTOPHAN DECARBOXYLASE, AND MONOAMINE OXIDASE IN BRAIN*
Bogdanski, D. F., Weissbach, H., & Udenfriend, S. (1957) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1957.tb12082.x · Cited by 346
A systems model of altered consciousness: integrating natural and drug-induced psychoses
Vollenweider, F. X., & Geyer, M. A. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00646-3 · Cited by 343
Serotonin Release as a Possible Mechanism of Reserpine Action
Pletscher, A., Shore, P. A., & Brodie, B. B. (1955) · Science · doi:10.1126/science.122.3165.374 · Cited by 336
Serotonin receptors involved in antidepressant effects
Artigas, F. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.09.006 · Cited by 311
The Serotonin-Producing Neurons of the Midbrain Median and Dorsal Raphe Nuclei
Azmitia, E. C. (1978) · Chemical Pathways in the Brain · doi:10.1007/978-1-4684-3183-4_5 · Cited by 288
Roth, B. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00019-9 · Cited by 287
Neurotransmitters and Suicidal Behavior: The Evidence from Cerebrospinal Fluid Studiesa
ÅSBERG, M. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb52359.x · Cited by 285
An excitatory synapse hypothesis of depression
Thompson, S. M., Kallarackal, A. J., Kvarta, M. D., Van Dyke, A. M., LeGates, T. A., & Cai, X. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.03.003 · Cited by 265
ACTIONS OF CERTAIN AMINES ON CEREBRAL CORTICAL NEURONES
KRNJEVIĆ, K., & PHILLIS, J. W. (1963) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1963.tb01484.x · Cited by 283
A possible correlation between drug-induced hallucinations in man and a behavioural response in mice
Corne, S. J., & Pickering, R. W. (1967) · Psychopharmacologia · doi:10.1007/bf00401509 · Cited by 271
INCREASE IN TISSUE SEROTONIN FOLLOWING ADMINISTRATION OF ITS PRECURSOR 5-HYDROXYTRYPTOPHAN
Udenfriend, S., Weissbach, H., & Bogdanski, D. F. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64972-5 · Cited by 271
A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma)
Sjoerdsma, A., Weissbach, H., & Udenfriend, S. (1956) · The American Journal of Medicine · doi:10.1016/0002-9343(56)90136-x · Cited by 267
Dawson, L. A., & Watson, J. M. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00067.x · Cited by 262
A review of the role of serotonin receptors in psychiatric disorders
Naughton, M., Mulrooney, J. B., & Leonard, B. E. (2000) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/1099-1077(200008)15:6<397::aid-hup212>3.0.co;2-l · Cited by 258
The 5-HT3receptor as a therapeutic target
Thompson, A. J., & Lummis, S. C. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.4.527 · Cited by 257
Roth, B., Hanizavareh, S. M., & Blum, A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1683-8 · Cited by 257
Béïque, J.-C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700436104 · Cited by 229
Fifty years chlorpromazine: a historical perspective
Ban, T. A. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a922 · Cited by 227
Clinical applications of hallucinogens: a review
Garcia-Romeu, A., Kersgaard, B., & Addy, P. H. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000084 · Cited by 201
“At the time these compounds, LSD in particular, were seminal in the field of neurochemistry, where they helped advance our understanding of serotonin, and its role in the brain (Aghajanian & Marek, 1999; Brodie & Shore, 1957; Cozzi, 2013; Whitaker-Azmitia, 1999; Woolley & Shaw, 1954a, 1954b, 1957).”
BackgroundThe serotonergic system in Parkinson's disease
Huot, P., Fox, S. H., & Brotchie, J. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.004 · Cited by 195
Serotonin and the regulation of mammalian energy balance
Donovan, M. H., & Tecott, L. H. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00036 · Cited by 150
Sarter, M., Bruno, J. P., & Parikh, V. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301285 · Cited by 100
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1772054 · Cited by 94
“tion with its structural similarity to the recently discovered serotonin lead to the first proposal in 1954 that serotonin might play a significant role in mental illness [33,126].”
BackgroundKetamine and the Future of Rapid-Acting Antidepressants
Riggs, L. M., & Gould, T. D. (2021) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-072120-014126 · Cited by 87
Effect of some indolealkylamines on man
TURNER, W. J. (1959) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1959.02340130141020 · Cited by 88
Association between a promoter variant in the monoamine oxidase A gene and schizophrenia
Jönsson, E. G., Norton, N., Forslund, K., Mattila-Evenden, M., Rylander, G., Åsberg, M., Owen, M. J., & Sedvall, G. C. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00224-4 · Cited by 57
The Neuronatomy of the Serotonergic System
Hornung, J.-P. (2010) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(10)70071-0 · Cited by 45
Metadata
- Authors
- Woolley, D. W., & Shaw, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1954-04
- Volume
- 40
- Issue
- 4
- Pages
- 228-231
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1992795970
- Cited by
- 602
- References
- 4
- FWCI
- 22.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.